1. Home
  2. Stock quotes
  3. C4 Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
C4 Therapeutics logo
C4 Therapeutics CCCC
$ 4.26 6.26%
mail-toReport an Error

Quarterly report 2024-Q3
added 10-31-2024

report update icon

C4 Therapeutics EV/EBITDA Ratio 2011-2024 | CCCC

Annual EV/EBITDA Ratio C4 Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-18.8 -22.1 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-18.8 -22.1 -20.5